Concord Wealth Partners Amgen Inc Transaction History

Concord Wealth Partners

$591 Million
Q3 2024

A detailed history of Concord Wealth Partners transactions in Amgen Inc stock. As of the latest transaction made, Concord Wealth Partners holds 8,524 shares of AMGN stock, worth $2.25 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

8,524

Previous 8,183 4.17%

Holding current value

$2.25 Million

Previous $2.56 Million 7.43%

% of portfolio

0.46%

Previous 0.46%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $105,498 - $115,046	341 Added 4.17%	8,524 $2.75 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $70,942 - $86,213	270 Added 3.41%	8,183 $2.56 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $315,115 - $380,384	1,172 Added 17.39%	7,913 $2.25 Million
Q4 2023 Apr 30, 2024	BUY	$255.7 - $288.46 $462,561 - $521,824	1,809 Added 36.68%	6,741 $1.94 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $462,561 - $521,824	1,809 Added 36.68%	6,741 $1.94 Million
Q3 2023 Apr 30, 2024	SELL	$218.65 - $271.46 $395,537 - $491,071	-1,809 Reduced 26.84%	4,932 $1.33 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $3,061 - $3,800	14 Added 0.28%	4,932 $1.33 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $323,547 - $382,588	1,510 Added 44.31%	4,918 $1.09 Million
Q1 2023 Apr 26, 2023	SELL	$225.79 - $275.2 $70,446 - $85,862	-312 Reduced 8.39%	3,408 $823,000
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $74,892 - $95,160	-327 Reduced 8.08%	3,720 $977,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $19,303 - $21,770	86 Added 2.17%	4,047 $912,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $74,980 - $83,440	325 Added 8.94%	3,961 $964,000
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $100,425 - $111,097	458 Added 14.41%	3,636 $879,000
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $381,252 - $436,309	1,917 Added 152.02%	3,178 $715,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $195,925 - $229,550	-923 Reduced 42.26%	1,261 $268,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $55,358 - $61,416	237 Added 12.17%	2,184 $532,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $204,601 - $238,429	922 Added 89.95%	1,947 $484,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $221,789 - $264,111	1,025 New	1,025 $236,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Account

Concord Wealth Partners Amgen Inc Transaction History